FDA Considers Tightening Regulations for Direct-to-Consumer Advertising

Abstract

In August, the Pharmaceutical Researchers and Manufacturers of America (PhRMA) sought to curb growing public criticism over its consumer advertising practices by releasing voluntary advertising guidelines. The document stated that drug advertising should serve the public health by “increasing awareness about diseases” and “educating patients about treatment options.”